period,total_demand,total_supply,shortage_amount,unsold,shortage_percentage,disrupted_manufacturers,fda_announcement
0,1.2,0.9,0.29999999999999993,0.0,0.24999999999999994,[0],
1,1.5,0.9,0.6,0.0,0.39999999999999997,[0],The FDA is aware of emerging supply disruptions affecting certain medications. We encourage manufacturers to report any production issues and are monitoring the situation closely to ensure patient needs are met.
2,1.5,0.9,0.6,0.0,0.39999999999999997,[0],The FDA is aware of an emerging shortage in the market. We encourage manufacturers to report any production disruptions and coordinate with stakeholders to mitigate impacts. Buyers should avoid stockpiling to ensure equitable distribution.
3,1.3,1.05,0.25,0.050000000000000044,0.1923076923076923,[0],The FDA is aware of an emerging shortage of a critical medication. We are actively monitoring the situation and encourage manufacturers to report any production disruptions. Stakeholders are advised to coordinate to ensure continued patient access.
4,1.2,1.05,0.1499999999999999,0.050000000000000044,0.12499999999999993,[0],The FDA is aware of emerging supply disruptions affecting certain medications. We encourage manufacturers to report any production challenges and buyers to maintain normal purchasing patterns to avoid exacerbating the situation.
5,1.5,1.05,0.44999999999999996,0.050000000000000044,0.3,[0],The FDA is aware of an emerging shortage affecting the supply of a critical medication. We encourage manufacturers to increase production and stakeholders to coordinate efforts to ensure patient access. Please report any supply disruptions to the FDA.
6,1.5,1.245,0.2549999999999999,0.2450000000000001,0.16999999999999993,[0],The FDA is aware of emerging supply challenges in the market and is actively monitoring the situation. We encourage manufacturers and healthcare providers to report any supply disruptions and to coordinate efforts to ensure patient access.
7,1.5,1.076,0.42399999999999993,0.07600000000000007,0.2826666666666666,"[0, 1]",The FDA is aware of an emerging shortage affecting critical medications. We are actively monitoring the situation and encourage manufacturers to report any production challenges. Stakeholders are advised to coordinate efforts to mitigate impacts.
